Peer AI

Name: Peer AI
Brand: Peer AI

AI Native

With AI-powered solutions, Peer is clearing the path for important scientific discoveries, for a brighter future for all

Est 2023|Raised $12.1M

LinkedIn 3K|Website|FTEs 26|HQ San Francisco, California, US

01Competitive Landscape

Narrative analysis

- Peer AI vs. Certara CoAuthor: Certara is an established life sciences software and services vendor; CoAuthor is positioned as a generative-AI regulatory writing platform. Peer AI may appeal to teams seeking a focused workflow vendor, while Certara may be selected where procurement values vendor maturity and existing relationships. - Peer AI vs. Yseop Copilot: Yseop has established positioning in automated regulatory/medical writing. Peer AI's differentiation depends on workflow orchestration and output quality from structured data; these aspects should be validated in a pilot. - Peer AI vs. Artos AI: Artos publishes entry pricing, which can reduce procurement friction for smaller teams. Peer AI appears oriented toward enterprise and mid-market buyers with a sales-led engagement model.

Market adoption signals

A recent funding announcement indicates investor interest in the category of workflow-oriented AI for regulatory documentation.
The lack of independent reviews suggests either an early-stage installed base, limited public review activity by customers, or constrained public disclosure due to regulated contexts.

	Peer AI (vendor website)	Certara CoAuthor™	Artos AI
Starting Price	Not publicly posted (sales-led)	Not clearly posted on public page (sales-led)	Public pricing shown (e.g., Basic and Enterprise tiers)
Typical Fit	Regulated life sciences teams seeking a focused drafting workflow	Organizations invested in Certara ecosystem or seeking integrated regulatory writing tooling	Individuals or small teams seeking lower-friction tools; enterprises seeking transparent entry pricing
Key Strengths	Domain focus on regulatory documents; vendor states SOC 2/GDPR compliance; workflow orchestration features	Established life-sciences vendor footprint; regulatory tooling credibility	Transparent pricing; clear feature list around drafting and templates
Key Weaknesses	Limited independent reviews; limited public security artifacts; pricing opacity	Pricing opacity; platform may require substantial implementation depending on ecosystem	May require validation for large-scale regulated enterprise processes

01Competitive Landscape

Narrative analysis

Peer AI vs. Certara CoAuthor: Certara is an established life sciences software and services vendor; CoAuthor is positioned as a generative-AI regulatory writing platform. Peer AI may appeal to teams seeking a focused workflow vendor, while Certara may be selected where procurement values vendor maturity and existing relationships.
Peer AI vs. Yseop Copilot: Yseop has established positioning in automated regulatory/medical writing. Peer AI's differentiation depends on workflow orchestration and output quality from structured data; these aspects should be validated in a pilot.
Peer AI vs. Artos AI: Artos publishes entry pricing, which can reduce procurement friction for smaller teams. Peer AI appears oriented toward enterprise and mid-market buyers with a sales-led engagement model.

Market adoption signals

A recent funding announcement indicates investor interest in the category of workflow-oriented AI for regulatory documentation.
The lack of independent reviews suggests either an early-stage installed base, limited public review activity by customers, or constrained public disclosure due to regulated contexts.

	Peer AI (vendor website)	Certara CoAuthor™	Artos AI
Starting Price	Not publicly posted (sales-led)	Not clearly posted on public page (sales-led)	Public pricing shown (e.g., Basic and Enterprise tiers)
Typical Fit	Regulated life sciences teams seeking a focused drafting workflow	Organizations invested in Certara ecosystem or seeking integrated regulatory writing tooling	Individuals or small teams seeking lower-friction tools; enterprises seeking transparent entry pricing
Key Strengths	Domain focus on regulatory documents; vendor states SOC 2/GDPR compliance; workflow orchestration features	Established life-sciences vendor footprint; regulatory tooling credibility	Transparent pricing; clear feature list around drafting and templates
Key Weaknesses	Limited independent reviews; limited public security artifacts; pricing opacity	Pricing opacity; platform may require substantial implementation depending on ecosystem	May require validation for large-scale regulated enterprise processes

Peer AI

01Competitive Landscape

Narrative analysis

Market adoption signals

02Market Map

01Competitive Landscape

Narrative analysis

Market adoption signals

02Market Map